Geode Capital Management’s ENDRA Life Sciences NDRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-76,171
| Closed | -$7.4K | – | 4564 |
|
|
2024
Q2 | $7.4K | Buy |
76,171
+21,929
| +40% | +$2.13K | ﹤0.01% | 4558 |
|
|
2024
Q1 | $31.5K | Buy |
54,242
+2,059
| +4% | +$1.2K | ﹤0.01% | 4405 |
|
|
2023
Q4 | $111K | Buy |
52,183
+2,816
| +6% | +$5.97K | ﹤0.01% | 4154 |
|
|
2023
Q3 | $55.3K | Sell |
49,367
-8,687
| -15% | -$9.74K | ﹤0.01% | 4396 |
|
|
2023
Q2 | $82.4K | Buy |
58,054
+39,142
| +207% | +$55.6K | ﹤0.01% | 4394 |
|
|
2023
Q1 | $42.9K | Sell |
18,912
-290
| -2% | -$658 | ﹤0.01% | 4554 |
|
|
2022
Q4 | $78K | Sell |
19,202
-325,790
| -94% | -$1.32M | ﹤0.01% | 4478 |
|
|
2022
Q3 | $105K | Hold |
344,992
| – | – | ﹤0.01% | 4547 |
|
|
2022
Q2 | $80K | Buy |
344,992
+21,313
| +7% | +$4.94K | ﹤0.01% | 4659 |
|
|
2022
Q1 | $126K | Hold |
323,679
| – | – | ﹤0.01% | 4569 |
|
|
2021
Q4 | $223K | Hold |
323,679
| – | – | ﹤0.01% | 4426 |
|
|
2021
Q3 | $559K | Buy |
323,679
+7,197
| +2% | +$12.4K | ﹤0.01% | 3980 |
|
|
2021
Q2 | $689K | Buy |
316,482
+60,182
| +23% | +$131K | ﹤0.01% | 3786 |
|
|
2021
Q1 | $666K | Buy |
256,300
+192,372
| +301% | +$500K | ﹤0.01% | 3711 |
|
|
2020
Q4 | $47K | Hold |
63,928
| – | – | ﹤0.01% | 4178 |
|
|
2020
Q3 | $46K | Hold |
63,928
| – | – | ﹤0.01% | 4027 |
|
|
2020
Q2 | $61K | Hold |
63,928
| – | – | ﹤0.01% | 3948 |
|
|
2020
Q1 | $46K | Buy |
63,928
+1,053
| +2% | +$758 | ﹤0.01% | 3939 |
|
|
2019
Q4 | $105K | Hold |
62,875
| – | – | ﹤0.01% | 3970 |
|
|
2019
Q3 | $66K | Hold |
62,875
| – | – | ﹤0.01% | 4030 |
|
|
2019
Q2 | $107K | Buy |
62,875
+11,771
| +23% | +$20K | ﹤0.01% | 3945 |
|
|
2019
Q1 | $84K | Buy |
51,104
+3,344
| +7% | +$5.5K | ﹤0.01% | 3932 |
|
|
2018
Q4 | $71K | Buy |
+47,760
| New | +$71K | ﹤0.01% | 3924 |
|